Radionuclides	NNS	O
used	VBN	O
in	IN	O
PET	NNP	O
scanning	NN	O
are	VBP	B
typically	RB	I
isotopes	NNS	O
with	IN	O
short	JJ	O
half	NN	O
lives	VBZ	O
such	JJ	O
as	IN	O
carbon-11	NN	O
(	-LRB-	O
~20	NNP	O
min	NNP	O
)	-RRB-	O
,	,	B
nitrogen-13	NN	O
(	-LRB-	O
~10	NNP	O
min	NNP	O
)	-RRB-	O
,	,	B
oxygen-15	NN	O
(	-LRB-	O
~2	NNP	O
min	NNP	O
)	-RRB-	O
,	,	B
and	CC	I
fluorine-18	NN	O
(	-LRB-	O
~110	NNP	O
min	NN	O
)	-RRB-	O
.	.	O
These	DT	O
radionuclides	NNS	O
are	VBP	B
incorporated	VBN	O
either	CC	O
into	IN	O
compounds	NNS	O
normally	RB	O
used	VBN	O
by	IN	O
the	DT	B
body	NN	O
such	JJ	O
as	IN	O
glucose	NN	O
(	-LRB-	O
or	CC	B
glucose	NN	O
analogues	NNS	O
)	-RRB-	O
,	,	B
water	NN	O
or	CC	B
ammonia	NN	O
,	,	B
or	CC	I
into	IN	O
molecules	NNS	O
that	WDT	O
bind	VBP	O
to	IN	B
receptors	NNS	O
or	CC	B
other	JJ	I
sites	NNS	B
of	IN	I
drug	NN	O
action	NN	O
.	.	O

Such	JJ	O
labelled	VBN	O
compounds	NNS	O
are	VBP	B
known	VBN	I
as	IN	O
radiotracers	NNS	O
.	.	O

It	PRP	B
is	VBZ	I
important	JJ	B
to	TO	I
recognize	VB	O
that	IN	O
PET	NNP	O
technology	NN	O
can	MD	B
be	VB	I
used	VBN	O
to	TO	B
trace	VB	O
the	DT	B
biologic	NN	O
pathway	NN	O
of	IN	B
any	DT	O
compound	NN	O
in	IN	O
living	VBG	O
humans	NNS	O
(	-LRB-	O
and	CC	B
many	JJ	I
other	JJ	B
species	NNS	I
as	RB	O
well	RB	B
)	-RRB-	O
,	,	B
provided	VBD	O
it	PRP	B
can	MD	I
be	VB	B
radiolabeled	VBN	O
with	IN	O
a	DT	B
PET	NNP	O
isotope	NN	O
.	.	O

Due	IN	O
to	IN	B
the	DT	I
short	JJ	O
half	NN	O
lives	NNS	O
of	IN	B
most	JJS	I
radioisotopes	NNS	O
,	,	B
the	DT	I
radiotracers	NNS	O
must	MD	O
be	VB	B
produced	VBN	O
using	VBG	O
a	DT	B
cyclotron	NN	O
and	CC	B
radiochemistry	NN	O
laboratory	NN	O
that	WDT	O
are	VBP	B
in	IN	O
close	JJ	O
proximity	NN	O
to	IN	B
the	DT	I
PET	NNP	O
imaging	NN	O
facility	NN	O
.	.	O

